Symptoms of Serotonin Syndrome
Serotonin syndrome presents with a clinical triad of mental status changes (confusion, agitation, anxiety), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, muscle rigidity), and autonomic hyperactivity (hypertension, tachycardia, arrhythmias, tachypnea, diaphoresis, shivering, vomiting, diarrhea). 1
Clinical Presentation by Severity
Early/Mild Symptoms
Symptoms typically arise within 24 to 48 hours after combining serotonergic medications or increasing doses 1:
- Mental status changes: Confusion, agitation, anxiety
- Neuromuscular signs: Tremor, hyperreflexia (most common finding)
- Autonomic signs: Diaphoresis, tachycardia, mild hypertension, shivering
Moderate to Severe Symptoms
Advanced symptoms can progress rapidly and include 1, 2:
- Fever (temperature can reach ≤41.1°C)
- Seizures
- Cardiac arrhythmias
- Unconsciousness
- Muscle rigidity (particularly in lower extremities, more pronounced than upper extremities)
Key Diagnostic Features
Clonus and hyperreflexia are highly diagnostic for serotonin syndrome when occurring in the setting of serotonergic drug use 2. The most common clinical finding is myoclonus, occurring in 57% of cases 2.
Specific Neuromuscular Findings to Look For:
- Ocular clonus (rapid horizontal eye movements)
- Inducible clonus (elicited by rapid dorsiflexion of the foot)
- Spontaneous clonus
- Hyperreflexia (may be masked by severe hypertonicity)
- Increased muscle tone (lower extremities > upper extremities) 2
Physical Examination Findings:
- Skin: Diaphoretic (profuse sweating)
- Pupils: Mydriasis (dilated pupils)
- Mucous membranes: Sialorrhea (excessive salivation)
- Gastrointestinal: Hyperactive bowel sounds, may have diarrhea 2
Timing and Onset
The syndrome typically develops within 6-24 hours of medication initiation, dose increase, or combining serotonergic agents 2. This rapid onset distinguishes it from neuroleptic malignant syndrome (which develops over days) and helps guide clinical suspicion.
Life-Threatening Complications
Severe cases can lead to 2:
- Rhabdomyolysis with elevated creatine kinase
- Metabolic acidosis
- Renal failure with elevated serum creatinine
- Disseminated intravascular coagulopathy
- Multi-organ failure
The mortality rate is approximately 11%, with about one-quarter of patients requiring intubation, mechanical ventilation, and ICU admission 2.
Clinical Pitfall
The presentation is extremely variable 2, ranging from mild agitation to life-threatening hyperthermia. This variability makes diagnosis challenging, and the condition is frequently underdiagnosed 3. Do not wait for the full triad to be present—early recognition based on neuromuscular signs (especially clonus and hyperreflexia) in the context of serotonergic drug use is critical for preventing progression to severe toxicity.